Overview

Treatment of Diffuse Large B Cell Lymphoma

Status:
Unknown status

Trial end date:
2018-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of Yangzhengxiaoji Capsule Combination Chemotherapy for III/IV Diffuse Large B Cell Lymphoma.

Phase:

Phase 4

Details

Lead Sponsor:

Mingzhi Zhang

Treatments:

Cyclophosphamide
Doxorubicin
Liposomal doxorubicin
Prednisolone
Prednisone
Vincristine